Vienna, Austria

Christoph Denk


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Christoph Denk - Pioneering Advances in PET Imaging

Introduction

Christoph Denk is an accomplished inventor based in Vienna, Austria, known for his innovative contributions to the field of medical imaging. With a focus on enhancing positron emission tomography (PET), Denk has developed groundbreaking technology that promises to improve clinical applications through advanced imaging probes.

Latest Patents

Denk holds a patent for "F-labeled novel tetrazines imaging probes for pretargeting in PET imaging." This invention features the development of novel F-labeled tetrazines that demonstrate high reactivity, making them effective for in vivo applications. The probes are tailored for pre-targeted PET imaging and exhibit accessible radiochemical yields, facilitating their use in clinical environments. Denk's F-labeled tetrazines were created using a copper-mediated click indirect labeling approach, enhancing their practical applicability. Notably, a specific compound includes an F-labeled azide synthon with a glucose linker and a triazole moiety, showing strong suitability for clinical pre-targeted imaging purposes.

Career Highlights

Throughout his career, Christoph Denk has made significant strides in his field, earning recognition for his innovative ideas and contributions. He has amassed a single patent that showcases his expertise in developing imaging probes that hold promise for enhancing medical diagnostics.

Collaborations

Denk has collaborated with renowned professionals in his field, including Andreas Kjær and Matthias Manfred Herth. His work at institutions such as Rigshospitalet and Københavns Universitet has further enriched his experience and contributed to the advancement of technologies in PET imaging.

Conclusion

Christoph Denk continues to be a significant figure in the realm of medical imaging, with his innovative F-labeled tetrazines poised to enhance the capabilities of PET imaging in clinical settings. His work exemplifies the intersection of creativity, research, and practical applications in the field of medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…